SlideShare a Scribd company logo
1 of 4
Download to read offline
THE FORUM FOR THE INDUSTRY EXECUTIVE
August 2005
www.pharmavoice.com
SPECIAL ISSUE
100
of the most inspiring
people in the industry
This is reprinted from PharmaVOICE August 2005
Copyright 2005 by PharmaLinx LLC
he PharmaVOICE 100 was
inspired by the men and
women who graciously con-
sent to share their insights on
the various trends and chal-
lenges facing the life-sciences
industry on a monthly basis.
We are continually fired up by their
knowledge and willingness to raise their
voices and bring their unique perspectives
to the industry at large.
Thus, we thought it was only appropri-
ate to showcase the men and women who
inspire and motivate you, our readers.
We asked our readership community to
identify the people who they believe are
having the greatest influence on corporate
leadership, research and development,
technology, creativity, marketing, and
strategy.
The PharmaVOICE 100 were selected
based on the number of nominations
received as well as on the write ups that
accompanied the submissions. We thank all
of you who took the time to provide us with
thoughtfully crafted accounts outlining why
an individual inspired or motivated you.
For the editors of PharmaVOICE this
first annual issue has been a special experi-
ence. While we speak with many influen-
tial people every month for our Forums and
feature articles, we rarely have the opportu-
nity to talk about their lives, both profes-
sionally and personally, their challenges,
and where they find inspiration and moti-
vation.
The 100 people profiled in this issue
hold a special place in their peers’ and col-
leagues’ lives. And we know why. We have
found — from the nominations that were
submitted and from speaking with these
leaders — just what makes these people so
inspiring.
Every one of the men and women pro-
filed in this special issue has a passion for
the industry, the work they do, their col-
leagues, and most importantly, the people
who are impacted by what they bring to the
table.
Their focus is clear: improving the dis-
covery, development, access, and under-
standing of life-improving and life-saving
medications.
Resoundingly, the leaders profiled for
this issue agree that at the end of the day it’s
about improving the quality of lives of
patients.
Their passion is felt by all those whose
lives they touch. They’ve made a concerted
effort to put a more human face on the life-
sciences industry. They have a personal
management style that stresses integrity,
decency, and character.
The PharmaVOICE 100 represent a
broad cross-section of industry sectors —
pharmaceutical, biotechnology, contract
research, clinical trials, research and devel-
opment, patient education, patient recruit-
ment, advertising, technology, and many
others.
To make the navigation of this issue as
easy as possible, we have segmented the
honorees into different categories. But by
no means is their influence one-dimension-
al. Most, if not all, of these leaders could be
featured in more than one category.
On behalf of the editorial team of
PharmaVOICE — Denise Myshko, Elisa-
beth Pena Villarroel, Kim Ribbink, and
Autumn Konopka — I want to thank our
100 for making this issue possible. We
look forward to many more inspiring con-
versations, and we can’t wait to see who
makes next year’s list.
Taren Grom
Editor
In keeping with PharmaVOICE’s mission
of providing insightful and provocative
commentary from leaders throughout the
life sciences,it is our pleasure,and honor,to
publish the first annual PharmaVOICE 100
in recognition of their contributions to
the industry.
TTaarreenn GGrroomm
ThePharmaVOICE100
PUBLISHER Lisa Banket
EDITOR Taren Grom
CREATIVE DIRECTOR Marah Walsh
MANAGING EDITOR
Denise Myshko
ASSOCIATE EDITOR
Elisabeth Pena Villarroel
FEATURES EDITOR
Kim Ribbink
CONTRIBUTING EDITORS
Autumn Konopka
DESIGN ASSOCIATE
Cathy Liszewski
NATIONAL ACCOUNT MANAGERS
Melissa Drozdoff
Cathy Tracy
SALES REPRESENTATIVE
Jayme Hudson
CIRCULATION ASSISTANT
Robert Harrison
Copyright 2005
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Five, Number Eight
PharmaVOICE is published 12 times per year by Pharma-
Linx LLC, P.O. Box 327, Titusville, NJ 08560. Application to
mail at Periodicals Postage Rates is pending at Titusville,
NJ 08560 and additional mailing offices.
Postmaster: Send address changes to PharmaVOICE,
P.O. Box 327, Titusville, NJ 08560.
PharmaVOICE Coverage and Distribution:
Domestic subscriptions are available at $190 for one
year (12 issues). Foreign subscriptions: 12 issues
US$360. Contact PharmaVOICE at P.O. Box 327,
Titusville, NJ 08560. Call us at 609.730.0196 or FAX your
order to 609.730.0197.
Contributions: PharmaVOICE is not responsible for
unsolicited contributions of any type. Unless otherwise
agreed in writing, PharmaVOICE retains all rights on
material published in PharmaVOICE for a period of six
months after publication and reprint rights after that
period expires. E-mail: tgrom@pharmavoice.com.
Change of address: Pleaseallowsixweeksforachange
of address. Send your new address along with your sub-
scription label to PharmaVOICE, P.O. Box 327, Titusville,
NJ 08560. Call us at 609.730.0196 or FAX your change to
609.730.0197. E-mail: mwalsh@pharmavoice.com.
IMPORTANT NOTICE: The post office will not forward
copies of this magazine. PharmaVOICE is not respon-
sible for replacing undelivered copies due to lack of or
late notification of address change.
Advertising in PharmaVOICE: To advertise in Pharma-
VOICE please contact our Advertising Department at
P.O. Box 327, Titusville, NJ 08560, or telephone us at
609.730.0196. E-mail: lbanket@pharmavoice.com.
www.pharmavoice.com
THE FORUM FOR THE INDUSTRY EXECUTIVE
Volume 5 • Number 8
Send your letters to feedback@pharma-
voice.com. Please include your name, title,
company, and business phone number. Let-
ters chosen for publication may be edited for
length and clarity. All submissions become
the property of PharmaLinx LLC.
Letters
T
2 A u g u s t 2 0 0 5 PharmaVOICE
PharmaVOICE 100
The Commanders and Chiefs......10
Thomas L. Adams, L.H.D., CAE
Mark J. Ahn, Ph.D.
Glenn Bilawsky
John Cline
Scott D. Cotherman
Cameron Durrant, M.D., MBA
Matt Giegerich
Dennis Gillings, CBE, Ph.D.
Joseph L. Herring
Louisa Holland
Nancy Lurker
Alan MacKenzie
David Mott
Barbara Pritchard
Robert R. Ruffolo Jr., Ph.D.
John Ryals, Ph.D.
Kuslima Shogen
Martin Soeters
Susan Stein
Brad Thompson, Ph.D.
David S. Tierney, M.D.
Susan Torroella
Donato Tramuto
Richard Vanderveer, Ph.D.
Daniel Vasella, M.D.
Lynn O’Connor Vos
Blane Walter
The Risk Takers ..............................32
Jeffrey S. Aronin
Joan F. Bachenheimer
John Bailye
Paul Bleicher, M.D., Ph.D.
Bonnie A. Brescia
Lance Converse
Patricia Daly
Doug Engfer
Scott Freedman
Victoria Hale, Ph.D.
Paul Janssen, M.D., Ph.D.
Mary Ann Liebert
Lukas Makris, Ph.D.
Stacy Mamarkos Martin
Neil Matheson
Ed Mitzen
Elizabeth Moench
Michael Morales
Philip Patrick
Charlene Prounis
Jean-Pierre Sommadossi, Ph.D., Pharm.D.
Terrence O. Tormey
Lois Trench-Hines
Ruth Vukelich
The Researchers & Scientists ......46
Daniel B. Carr, M.D.
Anders Ekblom, M.D., Ph.D.,D.D.S.
The Researchers and Scientists (continued)
Boris Golubtsov, M.D., Ph.D.
Maurice R. Hilleman, Ph.D.
Eduard E. Holdener, M.D.
Amir Kalali, M.D.
Susan Orr, O.D.
Allen David Roses, M.D.
Lorin Roskos, Ph.D.
Dr. Leo H. Sternbach
Dr. Giulio Vita
The Practitioners........................54
Lawrence H. Schwartz, M.D.
Stephen F. Sener, M.D.
The Brand Builders ....................56
Jay Carter
Marty Driscoll
Larry Star
David Stern
Dale Taylor
David Wood
The Technologists ......................62
Christopher Ahlberg, Ph.D.
Howard Asher
Philip J. Brennan
Edward Ikeguchi, M.D.
Jinsoo Kim
Robert Lyons, Ph.D.
Michael O’Connell, Ph.D.
Zack Rinat
Nancy Smerkanich
The Mentors..................................68
Donna Berk, M.S.
Clifford Kalb
S. Machelle Manuel, Ph.D.
Mario R. Nacinovich Jr.
Jon Wallace
Robin L. Winter-Sperry, M.D.
The Change Agents ....................72
Murray L. Aitken
Barry Arnold, M.B., B.Ch.
Jack Barrette
Grant Corbett
Teri P. Cox
Chris Downey
Philip P. Gerbino, Pharm.D.
Anjali Kataria
Kevin McMurtry
Joy Morrell
Theresa Kane Musser
Edward Penhoet, Ph.D.
Timothy Pratt, Ph.D.
Amrit Ray, M.D.
Robert Swanson
WHO’S ON THE LIST — 2005 Indexed by Section
3PharmaVOICE A u g u s t 2 0 0 5
100PharmaVOICE
The Risk Takers
The RiskTakers
Embodying the true spirit of entrepreneurialism,
these individuals identified an unmet need in the
industry and have successfully built companies to
fulfill their visions.
Through the Patients’Eyes
EXPERIENCEWITH DTC ADVERTISING,AN INTEREST IN DIRECT-TO-PATIENT
COMMUNICATIONS,AND A PASSION FOR BREAKING NEW GROUND have
proven to be the perfect recipe for success for Elizabeth Moench.Taking her knowl-
edge of the industry,FDA regulations,patient marketing,public affairs,issues man-
agement,and an uncanny ability to identify trends,Ms.Moench seized the opportu-
nity in 1992 to form her own certified woman-owned company,MediciGroup Inc.
Grown from a handful of employees with one client,MediciGroup is now a leader in
the development and implementation of direct-to-patient clinical-trial recruitment
and retention programs.Today,with a team of 30 professionals,the company serves
a worldwide client base.
Maintaining the core value that everything the company does needs to be evalu-
ated through a patient’s eyes,Ms.Moench has overcome the“white coat”mentality
that treated patients simply as statistics and has developed unique programs that
address issues critical to successful clinical-study completion.
With a unique perspective — having both European and American roots —
she is sensitive to cultural differences and is transferring those insights to global
patient recruitment and retention programs.
Her dedication,innovative spirit,and commitment continuously inspire her
employees,peers,associates,and clients.As president,Ms.Moench strives to inspire
those around her,creating an environment for employees that meets both their needs
and the needs of the company.
Ms.Moench is active with the DIA and the Association of Managed
Care Pharmacy;she has served as past chair of the public affairs section
for PhRMA and as a former board member of the National Council on
Patient Information and Education.She has been recognized for her
contributions — throughout the industry and beyond — with
numerous awards,including theYWCA Award forWomen in Indus-
try,a Gold Quill Award from the International Association of Business
Communications,and chair of Health Decisions of New Jersey.
Dedication,innovation,commitment — three words that have big meaning
when describing the contributions that Elizabeth Moench,Founder and
President of MediciGroup Inc.,is making to the industry.
Elizabeth Moench

More Related Content

Viewers also liked

3 Megatrends Impacting Designs of Robotics in Life Sciences | Parker Hannifin
3 Megatrends Impacting Designs of Robotics in Life Sciences | Parker Hannifin3 Megatrends Impacting Designs of Robotics in Life Sciences | Parker Hannifin
3 Megatrends Impacting Designs of Robotics in Life Sciences | Parker HannifinParker Hannifin Corporation
 
Marcus Evans Profile _ Liz Moench, CEO MediciGlobal
Marcus Evans Profile _ Liz Moench, CEO MediciGlobalMarcus Evans Profile _ Liz Moench, CEO MediciGlobal
Marcus Evans Profile _ Liz Moench, CEO MediciGloballmoench
 
Recommendation Letter
Recommendation LetterRecommendation Letter
Recommendation LetterThu Khong
 
Kelsea Magel CV 03.15.16
Kelsea Magel CV 03.15.16 Kelsea Magel CV 03.15.16
Kelsea Magel CV 03.15.16 Kelsea Magel
 

Viewers also liked (6)

3 Megatrends Impacting Designs of Robotics in Life Sciences | Parker Hannifin
3 Megatrends Impacting Designs of Robotics in Life Sciences | Parker Hannifin3 Megatrends Impacting Designs of Robotics in Life Sciences | Parker Hannifin
3 Megatrends Impacting Designs of Robotics in Life Sciences | Parker Hannifin
 
Marcus Evans Profile _ Liz Moench, CEO MediciGlobal
Marcus Evans Profile _ Liz Moench, CEO MediciGlobalMarcus Evans Profile _ Liz Moench, CEO MediciGlobal
Marcus Evans Profile _ Liz Moench, CEO MediciGlobal
 
Parker Hannifin 2016 Sustainability Report
Parker Hannifin 2016 Sustainability Report Parker Hannifin 2016 Sustainability Report
Parker Hannifin 2016 Sustainability Report
 
Recommendation Letter
Recommendation LetterRecommendation Letter
Recommendation Letter
 
Kelsea Magel CV 03.15.16
Kelsea Magel CV 03.15.16 Kelsea Magel CV 03.15.16
Kelsea Magel CV 03.15.16
 
Matfield animation #1
Matfield animation #1Matfield animation #1
Matfield animation #1
 

Similar to PharmaVoice_Aug_2005_Liz_Top_100

Peter Holden - Marketing Communications in the Pharmaceutical Industry-CRC Pr...
Peter Holden - Marketing Communications in the Pharmaceutical Industry-CRC Pr...Peter Holden - Marketing Communications in the Pharmaceutical Industry-CRC Pr...
Peter Holden - Marketing Communications in the Pharmaceutical Industry-CRC Pr...AggieLainePiniones1
 
Pharmacy School Essay Examples.pdf
Pharmacy School Essay Examples.pdfPharmacy School Essay Examples.pdf
Pharmacy School Essay Examples.pdfJanet Rose
 
Pharmacy School Essay Examples
Pharmacy School Essay ExamplesPharmacy School Essay Examples
Pharmacy School Essay ExamplesLinda Bryant
 
The Evolution of the Pharma Industry
The Evolution of the Pharma IndustryThe Evolution of the Pharma Industry
The Evolution of the Pharma IndustryOnly Medics
 
DecodingCCCReport_FINAL
DecodingCCCReport_FINALDecodingCCCReport_FINAL
DecodingCCCReport_FINALBrittany Hill
 
10x-Program-2015
10x-Program-201510x-Program-2015
10x-Program-2015davesheppa
 
The 10 Most Admired Leaders in Pharmaceuticals, 2023 (1).pdf
The 10 Most Admired Leaders in Pharmaceuticals, 2023 (1).pdfThe 10 Most Admired Leaders in Pharmaceuticals, 2023 (1).pdf
The 10 Most Admired Leaders in Pharmaceuticals, 2023 (1).pdfCIO Look Magazine
 
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREADPinky Fadullon
 
Is pharma sick of its reputation?
Is pharma sick of its reputation? Is pharma sick of its reputation?
Is pharma sick of its reputation? Pascal Brabant
 
Careers in pharmaceuticals
Careers in pharmaceuticalsCareers in pharmaceuticals
Careers in pharmaceuticalsnyunuks
 
Business and Healthcare
Business and HealthcareBusiness and Healthcare
Business and Healthcarereachjoemar
 
Highlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesHighlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesExL Pharma
 
CAN INDIAN PHARMA STAY AHEAD OF THE ETHICS CURVE?
CAN INDIAN PHARMA STAY AHEAD OF THE ETHICS CURVE?CAN INDIAN PHARMA STAY AHEAD OF THE ETHICS CURVE?
CAN INDIAN PHARMA STAY AHEAD OF THE ETHICS CURVE?Anup Soans
 
PMRG 2008 Presentation
PMRG 2008 PresentationPMRG 2008 Presentation
PMRG 2008 PresentationDavid Lester
 
Final Campaign for IMC 618 at WVU
Final Campaign for IMC 618 at WVUFinal Campaign for IMC 618 at WVU
Final Campaign for IMC 618 at WVUAaron Weese
 
2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience 2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience GSW
 
Changing the Medical Research Paradigm
Changing the Medical Research ParadigmChanging the Medical Research Paradigm
Changing the Medical Research ParadigmRAWE_INC
 
Highlights From 7th Medical Science Liaison/MSL Conference
Highlights From 7th Medical Science Liaison/MSL ConferenceHighlights From 7th Medical Science Liaison/MSL Conference
Highlights From 7th Medical Science Liaison/MSL ConferenceExL Pharma
 

Similar to PharmaVoice_Aug_2005_Liz_Top_100 (20)

Peter Holden - Marketing Communications in the Pharmaceutical Industry-CRC Pr...
Peter Holden - Marketing Communications in the Pharmaceutical Industry-CRC Pr...Peter Holden - Marketing Communications in the Pharmaceutical Industry-CRC Pr...
Peter Holden - Marketing Communications in the Pharmaceutical Industry-CRC Pr...
 
Pharmacy School Essay Examples.pdf
Pharmacy School Essay Examples.pdfPharmacy School Essay Examples.pdf
Pharmacy School Essay Examples.pdf
 
Pharmacy School Essay Examples
Pharmacy School Essay ExamplesPharmacy School Essay Examples
Pharmacy School Essay Examples
 
The Evolution of the Pharma Industry
The Evolution of the Pharma IndustryThe Evolution of the Pharma Industry
The Evolution of the Pharma Industry
 
DecodingCCCReport_FINAL
DecodingCCCReport_FINALDecodingCCCReport_FINAL
DecodingCCCReport_FINAL
 
10x-Program-2015
10x-Program-201510x-Program-2015
10x-Program-2015
 
The 10 Most Admired Leaders in Pharmaceuticals, 2023 (1).pdf
The 10 Most Admired Leaders in Pharmaceuticals, 2023 (1).pdfThe 10 Most Admired Leaders in Pharmaceuticals, 2023 (1).pdf
The 10 Most Admired Leaders in Pharmaceuticals, 2023 (1).pdf
 
Insights success the 10 fastest growing pharmaceutical companies oct 2017
Insights success the 10 fastest growing pharmaceutical companies oct 2017Insights success the 10 fastest growing pharmaceutical companies oct 2017
Insights success the 10 fastest growing pharmaceutical companies oct 2017
 
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
(2286) World Orphan Drug Congress USA 2016 A4 32 Page Brochure 1.5 SCREEN SPREAD
 
Is pharma sick of its reputation?
Is pharma sick of its reputation? Is pharma sick of its reputation?
Is pharma sick of its reputation?
 
Careers in pharmaceuticals
Careers in pharmaceuticalsCareers in pharmaceuticals
Careers in pharmaceuticals
 
Business and Healthcare
Business and HealthcareBusiness and Healthcare
Business and Healthcare
 
Highlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best PracticesHighlights from ExL Pharma's 6th MSL Best Practices
Highlights from ExL Pharma's 6th MSL Best Practices
 
CAN INDIAN PHARMA STAY AHEAD OF THE ETHICS CURVE?
CAN INDIAN PHARMA STAY AHEAD OF THE ETHICS CURVE?CAN INDIAN PHARMA STAY AHEAD OF THE ETHICS CURVE?
CAN INDIAN PHARMA STAY AHEAD OF THE ETHICS CURVE?
 
PMRG 2008 Presentation
PMRG 2008 PresentationPMRG 2008 Presentation
PMRG 2008 Presentation
 
Showguide Magazine
Showguide MagazineShowguide Magazine
Showguide Magazine
 
Final Campaign for IMC 618 at WVU
Final Campaign for IMC 618 at WVUFinal Campaign for IMC 618 at WVU
Final Campaign for IMC 618 at WVU
 
2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience 2015 Pharmaceutical Sales Rep Experience
2015 Pharmaceutical Sales Rep Experience
 
Changing the Medical Research Paradigm
Changing the Medical Research ParadigmChanging the Medical Research Paradigm
Changing the Medical Research Paradigm
 
Highlights From 7th Medical Science Liaison/MSL Conference
Highlights From 7th Medical Science Liaison/MSL ConferenceHighlights From 7th Medical Science Liaison/MSL Conference
Highlights From 7th Medical Science Liaison/MSL Conference
 

More from lmoench

Patient centric site training to enhance clinical trial performance
Patient centric site training to enhance clinical trial performancePatient centric site training to enhance clinical trial performance
Patient centric site training to enhance clinical trial performancelmoench
 
Privacy Balance Sought - Letter to Editor - Applied Clinical Trials 2001
Privacy Balance Sought - Letter to Editor - Applied Clinical Trials 2001Privacy Balance Sought - Letter to Editor - Applied Clinical Trials 2001
Privacy Balance Sought - Letter to Editor - Applied Clinical Trials 2001lmoench
 
Risk assessment of pharmacueticals
Risk assessment of pharmacueticalsRisk assessment of pharmacueticals
Risk assessment of pharmacueticalslmoench
 
history-of-pharmaceutical-advertising_thesis
history-of-pharmaceutical-advertising_thesishistory-of-pharmaceutical-advertising_thesis
history-of-pharmaceutical-advertising_thesislmoench
 
15.-Clinical-Trial-Retention...
15.-Clinical-Trial-Retention...15.-Clinical-Trial-Retention...
15.-Clinical-Trial-Retention...lmoench
 

More from lmoench (6)

Patient centric site training to enhance clinical trial performance
Patient centric site training to enhance clinical trial performancePatient centric site training to enhance clinical trial performance
Patient centric site training to enhance clinical trial performance
 
Privacy Balance Sought - Letter to Editor - Applied Clinical Trials 2001
Privacy Balance Sought - Letter to Editor - Applied Clinical Trials 2001Privacy Balance Sought - Letter to Editor - Applied Clinical Trials 2001
Privacy Balance Sought - Letter to Editor - Applied Clinical Trials 2001
 
08001
0800108001
08001
 
Risk assessment of pharmacueticals
Risk assessment of pharmacueticalsRisk assessment of pharmacueticals
Risk assessment of pharmacueticals
 
history-of-pharmaceutical-advertising_thesis
history-of-pharmaceutical-advertising_thesishistory-of-pharmaceutical-advertising_thesis
history-of-pharmaceutical-advertising_thesis
 
15.-Clinical-Trial-Retention...
15.-Clinical-Trial-Retention...15.-Clinical-Trial-Retention...
15.-Clinical-Trial-Retention...
 

PharmaVoice_Aug_2005_Liz_Top_100

  • 1. THE FORUM FOR THE INDUSTRY EXECUTIVE August 2005 www.pharmavoice.com SPECIAL ISSUE 100 of the most inspiring people in the industry This is reprinted from PharmaVOICE August 2005 Copyright 2005 by PharmaLinx LLC
  • 2. he PharmaVOICE 100 was inspired by the men and women who graciously con- sent to share their insights on the various trends and chal- lenges facing the life-sciences industry on a monthly basis. We are continually fired up by their knowledge and willingness to raise their voices and bring their unique perspectives to the industry at large. Thus, we thought it was only appropri- ate to showcase the men and women who inspire and motivate you, our readers. We asked our readership community to identify the people who they believe are having the greatest influence on corporate leadership, research and development, technology, creativity, marketing, and strategy. The PharmaVOICE 100 were selected based on the number of nominations received as well as on the write ups that accompanied the submissions. We thank all of you who took the time to provide us with thoughtfully crafted accounts outlining why an individual inspired or motivated you. For the editors of PharmaVOICE this first annual issue has been a special experi- ence. While we speak with many influen- tial people every month for our Forums and feature articles, we rarely have the opportu- nity to talk about their lives, both profes- sionally and personally, their challenges, and where they find inspiration and moti- vation. The 100 people profiled in this issue hold a special place in their peers’ and col- leagues’ lives. And we know why. We have found — from the nominations that were submitted and from speaking with these leaders — just what makes these people so inspiring. Every one of the men and women pro- filed in this special issue has a passion for the industry, the work they do, their col- leagues, and most importantly, the people who are impacted by what they bring to the table. Their focus is clear: improving the dis- covery, development, access, and under- standing of life-improving and life-saving medications. Resoundingly, the leaders profiled for this issue agree that at the end of the day it’s about improving the quality of lives of patients. Their passion is felt by all those whose lives they touch. They’ve made a concerted effort to put a more human face on the life- sciences industry. They have a personal management style that stresses integrity, decency, and character. The PharmaVOICE 100 represent a broad cross-section of industry sectors — pharmaceutical, biotechnology, contract research, clinical trials, research and devel- opment, patient education, patient recruit- ment, advertising, technology, and many others. To make the navigation of this issue as easy as possible, we have segmented the honorees into different categories. But by no means is their influence one-dimension- al. Most, if not all, of these leaders could be featured in more than one category. On behalf of the editorial team of PharmaVOICE — Denise Myshko, Elisa- beth Pena Villarroel, Kim Ribbink, and Autumn Konopka — I want to thank our 100 for making this issue possible. We look forward to many more inspiring con- versations, and we can’t wait to see who makes next year’s list. Taren Grom Editor In keeping with PharmaVOICE’s mission of providing insightful and provocative commentary from leaders throughout the life sciences,it is our pleasure,and honor,to publish the first annual PharmaVOICE 100 in recognition of their contributions to the industry. TTaarreenn GGrroomm ThePharmaVOICE100 PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh MANAGING EDITOR Denise Myshko ASSOCIATE EDITOR Elisabeth Pena Villarroel FEATURES EDITOR Kim Ribbink CONTRIBUTING EDITORS Autumn Konopka DESIGN ASSOCIATE Cathy Liszewski NATIONAL ACCOUNT MANAGERS Melissa Drozdoff Cathy Tracy SALES REPRESENTATIVE Jayme Hudson CIRCULATION ASSISTANT Robert Harrison Copyright 2005 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Five, Number Eight PharmaVOICE is published 12 times per year by Pharma- Linx LLC, P.O. Box 327, Titusville, NJ 08560. Application to mail at Periodicals Postage Rates is pending at Titusville, NJ 08560 and additional mailing offices. Postmaster: Send address changes to PharmaVOICE, P.O. Box 327, Titusville, NJ 08560. PharmaVOICE Coverage and Distribution: Domestic subscriptions are available at $190 for one year (12 issues). Foreign subscriptions: 12 issues US$360. Contact PharmaVOICE at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197. Contributions: PharmaVOICE is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVOICE retains all rights on material published in PharmaVOICE for a period of six months after publication and reprint rights after that period expires. E-mail: tgrom@pharmavoice.com. Change of address: Pleaseallowsixweeksforachange of address. Send your new address along with your sub- scription label to PharmaVOICE, P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your change to 609.730.0197. E-mail: mwalsh@pharmavoice.com. IMPORTANT NOTICE: The post office will not forward copies of this magazine. PharmaVOICE is not respon- sible for replacing undelivered copies due to lack of or late notification of address change. Advertising in PharmaVOICE: To advertise in Pharma- VOICE please contact our Advertising Department at P.O. Box 327, Titusville, NJ 08560, or telephone us at 609.730.0196. E-mail: lbanket@pharmavoice.com. www.pharmavoice.com THE FORUM FOR THE INDUSTRY EXECUTIVE Volume 5 • Number 8 Send your letters to feedback@pharma- voice.com. Please include your name, title, company, and business phone number. Let- ters chosen for publication may be edited for length and clarity. All submissions become the property of PharmaLinx LLC. Letters T 2 A u g u s t 2 0 0 5 PharmaVOICE PharmaVOICE 100
  • 3. The Commanders and Chiefs......10 Thomas L. Adams, L.H.D., CAE Mark J. Ahn, Ph.D. Glenn Bilawsky John Cline Scott D. Cotherman Cameron Durrant, M.D., MBA Matt Giegerich Dennis Gillings, CBE, Ph.D. Joseph L. Herring Louisa Holland Nancy Lurker Alan MacKenzie David Mott Barbara Pritchard Robert R. Ruffolo Jr., Ph.D. John Ryals, Ph.D. Kuslima Shogen Martin Soeters Susan Stein Brad Thompson, Ph.D. David S. Tierney, M.D. Susan Torroella Donato Tramuto Richard Vanderveer, Ph.D. Daniel Vasella, M.D. Lynn O’Connor Vos Blane Walter The Risk Takers ..............................32 Jeffrey S. Aronin Joan F. Bachenheimer John Bailye Paul Bleicher, M.D., Ph.D. Bonnie A. Brescia Lance Converse Patricia Daly Doug Engfer Scott Freedman Victoria Hale, Ph.D. Paul Janssen, M.D., Ph.D. Mary Ann Liebert Lukas Makris, Ph.D. Stacy Mamarkos Martin Neil Matheson Ed Mitzen Elizabeth Moench Michael Morales Philip Patrick Charlene Prounis Jean-Pierre Sommadossi, Ph.D., Pharm.D. Terrence O. Tormey Lois Trench-Hines Ruth Vukelich The Researchers & Scientists ......46 Daniel B. Carr, M.D. Anders Ekblom, M.D., Ph.D.,D.D.S. The Researchers and Scientists (continued) Boris Golubtsov, M.D., Ph.D. Maurice R. Hilleman, Ph.D. Eduard E. Holdener, M.D. Amir Kalali, M.D. Susan Orr, O.D. Allen David Roses, M.D. Lorin Roskos, Ph.D. Dr. Leo H. Sternbach Dr. Giulio Vita The Practitioners........................54 Lawrence H. Schwartz, M.D. Stephen F. Sener, M.D. The Brand Builders ....................56 Jay Carter Marty Driscoll Larry Star David Stern Dale Taylor David Wood The Technologists ......................62 Christopher Ahlberg, Ph.D. Howard Asher Philip J. Brennan Edward Ikeguchi, M.D. Jinsoo Kim Robert Lyons, Ph.D. Michael O’Connell, Ph.D. Zack Rinat Nancy Smerkanich The Mentors..................................68 Donna Berk, M.S. Clifford Kalb S. Machelle Manuel, Ph.D. Mario R. Nacinovich Jr. Jon Wallace Robin L. Winter-Sperry, M.D. The Change Agents ....................72 Murray L. Aitken Barry Arnold, M.B., B.Ch. Jack Barrette Grant Corbett Teri P. Cox Chris Downey Philip P. Gerbino, Pharm.D. Anjali Kataria Kevin McMurtry Joy Morrell Theresa Kane Musser Edward Penhoet, Ph.D. Timothy Pratt, Ph.D. Amrit Ray, M.D. Robert Swanson WHO’S ON THE LIST — 2005 Indexed by Section 3PharmaVOICE A u g u s t 2 0 0 5 100PharmaVOICE
  • 4. The Risk Takers The RiskTakers Embodying the true spirit of entrepreneurialism, these individuals identified an unmet need in the industry and have successfully built companies to fulfill their visions. Through the Patients’Eyes EXPERIENCEWITH DTC ADVERTISING,AN INTEREST IN DIRECT-TO-PATIENT COMMUNICATIONS,AND A PASSION FOR BREAKING NEW GROUND have proven to be the perfect recipe for success for Elizabeth Moench.Taking her knowl- edge of the industry,FDA regulations,patient marketing,public affairs,issues man- agement,and an uncanny ability to identify trends,Ms.Moench seized the opportu- nity in 1992 to form her own certified woman-owned company,MediciGroup Inc. Grown from a handful of employees with one client,MediciGroup is now a leader in the development and implementation of direct-to-patient clinical-trial recruitment and retention programs.Today,with a team of 30 professionals,the company serves a worldwide client base. Maintaining the core value that everything the company does needs to be evalu- ated through a patient’s eyes,Ms.Moench has overcome the“white coat”mentality that treated patients simply as statistics and has developed unique programs that address issues critical to successful clinical-study completion. With a unique perspective — having both European and American roots — she is sensitive to cultural differences and is transferring those insights to global patient recruitment and retention programs. Her dedication,innovative spirit,and commitment continuously inspire her employees,peers,associates,and clients.As president,Ms.Moench strives to inspire those around her,creating an environment for employees that meets both their needs and the needs of the company. Ms.Moench is active with the DIA and the Association of Managed Care Pharmacy;she has served as past chair of the public affairs section for PhRMA and as a former board member of the National Council on Patient Information and Education.She has been recognized for her contributions — throughout the industry and beyond — with numerous awards,including theYWCA Award forWomen in Indus- try,a Gold Quill Award from the International Association of Business Communications,and chair of Health Decisions of New Jersey. Dedication,innovation,commitment — three words that have big meaning when describing the contributions that Elizabeth Moench,Founder and President of MediciGroup Inc.,is making to the industry. Elizabeth Moench